Why are analysts favoring Alphabet over Meta?
Analysts cite more conservative Street estimates and a lower valuation for Alphabet shares.
Yanuki
ARTICLE DETAIL
Alphabet (Google) Stock: Better Bet Than Meta? | California's Rising Insurance Costs: The Role of Personal Injury Lawyers | Entergy Launches US$2.18 Billion Equity Raise: What It Means for Investors | Tesla (TSLA) Stock Analysis: Challenges and Rebound Potential in 2026 | Mexican Peso Strengthens as Dollar Falls Amid Optimism | Chip Stock Rebound: Is SMH the Best Play? | Dell: Benefiting from the AI Infrastructure Boom | SanDisk Stock: Recent Volatility and Market Sentiment | Rocket Lab's Valuation: Beyond the Launch Story | Alphabet (Google) Stock: Better Bet Than Meta? | California's Rising Insurance Costs: The Role of Personal Injury Lawyers | Entergy Launches US$2.18 Billion Equity Raise: What It Means for Investors | Tesla (TSLA) Stock Analysis: Challenges and Rebound Potential in 2026 | Mexican Peso Strengthens as Dollar Falls Amid Optimism | Chip Stock Rebound: Is SMH the Best Play? | Dell: Benefiting from the AI Infrastructure Boom | SanDisk Stock: Recent Volatility and Market Sentiment | Rocket Lab's Valuation: Beyond the Launch Story
Finance / Stocks
Alphabet (Google) Stock: Better Bet Than Meta?
Shares of Alphabet (Google) have outperformed the S&P 500 and Magnificent 7 this year. Analysts are favoring Alphabet over Meta, citing valuation and conservative estimates. Goldman Sachs has raised its price target for Alphabet, reinforcin...
Key Insights
- Oppenheimer analysts prefer Alphabet (GOOG, GOOGL) over Meta (META), setting a price target of $300 for Alphabet and $825 for Meta.
- Goldman Sachs raised Alphabet’s price target to $288, maintaining a Buy rating, citing the company's leverage in artificial intelligence.
- Alphabet shares have gained 33% YTD as of October 15, 2025.
- The growth in usage of Gemini and core Search, coupled with a favorable Search antitrust verdict, has led to a healthy re-rating of Alphabet shares.
In-Depth Analysis
Alphabet Inc. (GOOGL) is recognized for its significant platforms, including Google Search, Google Maps, Gmail, and YouTube. The company is also heavily involved in cloud computing, quantum computing, and artificial intelligence research.
Goldman Sachs highlighted Alphabet as one of the most leveraged artificial intelligence companies, a view increasingly shared by investors. This perspective, combined with the growth of Gemini and core Search, and a more favorable outcome in the Search antitrust verdict, has contributed to the positive re-evaluation of Alphabet’s stock.
FAQ
What is Goldman Sachs’ price target for Alphabet?
Goldman Sachs raised its price target for Alphabet to $288 while maintaining a Buy rating.
What factors contributed to the positive re-rating of Alphabet shares?
Growth in usage of Gemini and core Search, along with a favorable Search antitrust verdict.
Takeaways
- Consider Alphabet (Google) as a potentially stronger investment compared to Meta, based on analyst evaluations and recent stock performance.
- Be aware of the factors driving Alphabet’s positive outlook, including its AI leverage and the growth of its core platforms.
- Note Goldman Sachs’ raised price target, indicating confidence in Alphabet’s future performance.
Discussion
Do you think Alphabet will continue to outperform Meta? Share your thoughts in the comments!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.